TransMedics (TMDX) Short-term Investments (2019 - 2022)

TransMedics' Short-term Investments history runs 4 years deep, the most recent figure standing at $27.7 million for Q2 2022.

• In Q2 2022, Short-term Investments fell 68.14% year-over-year to $27.7 million; the TTM figure through Jun 2022 stood at $27.7 million (down 68.14% YoY), while the FY2021 annual figure was $66.9 million, down 33.83% from the prior year.
• Short-term Investments was $27.7 million for Q2 2022 at TransMedics, down from $54.1 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $111.3 million in Q3 2020 to a low of $27.7 million in Q2 2022.
• Historically, Short-term Investments has averaged $70.4 million across 4 years, with a median of $67.4 million in 2019.
• The sharpest annual moves came in 2021 and 2022: Short-term Investments surged 91.12% in 2021, then plunged 68.14% in 2022.
• A 4-year view of Short-term Investments shows it stood at $60.6 million in 2019, then soared by 66.78% to $101.1 million in 2020, then slumped by 33.83% to $66.9 million in 2021, then sank by 58.58% to $27.7 million in 2022.
• The last three Short-term Investments figures came in at $27.7 million (Q2 2022), $54.1 million (Q1 2022), and $66.9 million (Q4 2021), per Business Quant data.